Pain Insights, Inc. announces a comprehensive market research study conducted among 1,044 patients with moderate-to-severe chronic pain and measured patient views/satisfaction/outcomes on the use of opioids, non-opioids, OTCs, and non-pharmacologic therapies for treatment of chronic pain. The report, published in July 2019, updates “Harmonizing Clinical Practice and Clinical Guidelines in the Management of Chronic Pain: — From the Patient Perspective” published in June 2017.
The updated report also looked at the impact of recent guideline recommendations on patient/practitioner views regarding opioids, the uptake of medical marijuana/cannabis, utilization of non-opioids and opioids for post-surgical pain (inpatient/outpatient).
Among the study’s key findings: Patients currently taking an opioid for chronic pain declined from 59% to 48% in the updated study; approximately one in five patients with chronic pain indicated they have tried medical marijuana/cannabis as part of their pain therapy; and moving forward patients are recommending a broader approach that can be tailored to individual needs and include pharmacologic, non-pharmacologic, cognitive and spiritual support.
Read more here